C-reactive protein: Risk factor, biomarker and/or therapeutic target?
- 1 March 2010
- journal article
- review article
- Published by Elsevier in Canadian Journal of Cardiology
- Vol. 26, 41A-44A
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Levels of C-Reactive Protein Associated with High and Very High Cardiovascular Risk Are Prevalent in Patients with Rheumatoid ArthritisPLOS ONE, 2009
- Novel and Conventional Biomarkers for Prediction of Incident Cardiovascular Events in the CommunityJAMA, 2009
- National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Emerging Biomarkers for Primary Prevention of Cardiovascular DiseaseClinical Chemistry, 2009
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine, 2008
- High-Sensitivity C-Reactive Protein and Coronary Heart Disease in a General Population of JapaneseArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- The metabolic syndrome—a new worldwide definitionThe Lancet, 2005
- Non–HDL Cholesterol, Apolipoproteins A-I and B100, Standard Lipid Measures, Lipid Ratios, and CRP as Risk Factors for Cardiovascular Disease in WomenJAMA, 2005
- C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart DiseaseNew England Journal of Medicine, 2004
- C-reactive protein: a critical updateJournal of Clinical Investigation, 2003
- C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular EventsCirculation, 2003